BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$19.87
-0.20 (-1.00%)
▼
5d:
+1.12%
30d:
+3.98%
90d:
+3.71%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 12, 2026
8d
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BAX shows positive signals but monitor for confirmation. Market pricing in 0.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: BAX shows positive signals but monitor for confirmation. Market pricing in 0.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.42
Based on -0.1% avg growth
INTRINSIC VALUE TODAY
$12.06
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $19.87, which is considered fair relative to its 30-day fair value range of $19.40 to $20.34. The stock's valuation (Forward PE: 8.8) is in line with its historical norms (8.6). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $20.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.13 (+16.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $20.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.13 (+16.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$19.40 -
$20.34
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($23.13)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$19.40 -
$20.34
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$19.23
Resistance Level
$20.45
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
8.76
Wall Street Target
$23.13
(+16.4%)
Revenue Growth (YoY)
5.0%
Earnings Growth (YoY)
237.9%
Profit Margin
-3.1%
Valuation Premium vs History
+0.6% premium
PE vs Historical
8.8 vs 8.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$19.99
(+1%)
2-Year Target
$20.11
(+1%)
3-Year Target
$20.23
(+2%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$19.86
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -4.1%)
$44.67
(+125%)
Base:
(SPY PE: 8.8, Growth: -4.1%)
$17.55
(-12%)
Bear:
(PE: 7.4, Growth: -4.1%)
$14.91
(-25%)
Last updated: February 03, 2026 4:37 AM ET
Data refreshes hourly during market hours. Next update: 5:37 AM
Data refreshes hourly during market hours. Next update: 5:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2025-09-29
Lisa C. McClain
BUY
2025-09-25
Ro Khanna
SELL
2025-09-05
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$612 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 56 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 57 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 62 BUY |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
